MMS22L

gene
On this page

Also known as dJ39B17.2

Summary

MMS22L (MMS22 like, DNA repair protein, HGNC:21475) is a protein-coding gene on chromosome 6q16.1, encoding Protein MMS22-like (Q6ZRQ5). Component of the MMS22L-TONSL complex, a complex that promotes homologous recombination-mediated repair of double-strand breaks (DSBs) at stalled or collapsed replication forks. It is a common-essential gene (DepMap: required in 99.3% of cancer cell lines).

The protein encoded by this gene forms a complex with tonsoku-like, DNA repair protein (TONSL), and this complex recognizes and repairs DNA double-strand breaks at sites of stalled or collapsed replication forks. The encoded protein also can bind with the histone-associated protein NFKBIL2 to help regulate the chromatin state at stalled replication forks. Finally, this gene appears to be overexpressed in most lung and esophageal cancers. Multiple transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 253714 — RefSeq curated summary.

At a glance

  • GWAS associations: 35
  • Clinical variants (ClinVar): 162 total
  • Cancer dependency (DepMap): dependent in 99.3% of screened cell lines (common-essential)
  • MANE Select transcript: NM_001350599

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21475
Approved symbolMMS22L
NameMMS22 like, DNA repair protein
Location6q16.1
Locus typegene with protein product
StatusApproved
AliasesdJ39B17.2
Ensembl geneENSG00000146263
Ensembl biotypeprotein_coding
OMIM615614
Entrez253714

Gene structure

Transcript identifiers

Ensembl transcripts: 16 — 8 protein_coding, 4 retained_intron, 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000275053, ENST00000369251, ENST00000482634, ENST00000484170, ENST00000496119, ENST00000506256, ENST00000508820, ENST00000508976, ENST00000509383, ENST00000510018, ENST00000511335, ENST00000514790, ENST00000683635, ENST00000929351, ENST00000929352, ENST00000929353

RefSeq mRNA: 3 — MANE Select: NM_001350599 NM_001350599, NM_001350600, NM_198468

CCDS: CCDS5039

Canonical transcript exons

ENST00000683635 — 25 exons

ExonStartEnd
ENSE000009747859714985397150020
ENSE000009747869714216197146887
ENSE000010841309717306397173222
ENSE000010841319716200297162165
ENSE000010841329716807197168240
ENSE000010841339716524697165457
ENSE000013254129715177197151867
ENSE000013679079717940897179559
ENSE000013708029722889497229403
ENSE000013715199718649797186690
ENSE000013717719718190497182054
ENSE000013802429717844397178585
ENSE000013852379723142697231652
ENSE000035046329727884997278898
ENSE000035062619727297597273062
ENSE000035165139724662897246690
ENSE000035544389727270497272881
ENSE000035790479728123797281362
ENSE000036241039728231497282553
ENSE000036332029725455797254733
ENSE000036422599726787297268002
ENSE000036423049726333597263448
ENSE000036920179726990297269992
ENSE000037910959723386197233980
ENSE000039221369728309697283216

Expression profiles

Bgee: expression breadth ubiquitous, 137 present calls, max score 89.41.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.3657 / max 182.1816, expressed in 1627 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
7478010.36571627

Top tissues by expression

140 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047389.41gold quality
ventricular zoneUBERON:000305387.30gold quality
embryoUBERON:000092284.92gold quality
ganglionic eminenceUBERON:000402384.92gold quality
bone marrowUBERON:000237183.56gold quality
bone marrow cellCL:000209283.44gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.33gold quality
corpus callosumUBERON:000233679.31gold quality
stromal cell of endometriumCL:000225577.90gold quality
adrenal tissueUBERON:001830377.86gold quality
tonsilUBERON:000237276.93gold quality
calcaneal tendonUBERON:000370176.77gold quality
islet of LangerhansUBERON:000000676.04gold quality
testisUBERON:000047375.90gold quality
endometriumUBERON:000129575.60gold quality
vermiform appendixUBERON:000115475.28gold quality
smooth muscle tissueUBERON:000113575.21gold quality
lymph nodeUBERON:000002974.83gold quality
monocyteCL:000057674.55gold quality
rectumUBERON:000105274.39gold quality
leukocyteCL:000073874.31gold quality
right testisUBERON:000453473.96gold quality
placentaUBERON:000198773.80gold quality
left testisUBERON:000453373.56gold quality
colonic epitheliumUBERON:000039773.48gold quality
cortical plateUBERON:000534373.29gold quality
lower esophagus mucosaUBERON:003583470.90gold quality
esophagus mucosaUBERON:000246970.66gold quality
pancreasUBERON:000126469.91gold quality
duodenumUBERON:000211469.91gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-6075yes883.09
E-MTAB-6678yes7.89
E-ANND-3yes7.00
E-GEOD-70580no168.82

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

170 targeting MMS22L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-8485100.0077.574731
HSA-MIR-98-3P100.0074.083907
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-126-5P100.0072.713180
HSA-MIR-3924100.0072.092394
HSA-MIR-5692A100.0074.406850
HSA-MIR-3163100.0077.238605
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-5193100.0067.261744
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-450099.9972.722367
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-428299.9975.366408
HSA-MIR-186-5P99.9970.833707
HSA-MIR-366299.9973.825684
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-1213699.9872.815713

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 99.3% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 9)

  • These results indicate that MMS22L and TONSL are genome caretakers that stimulate the recombination-dependent repair of stalled or collapsed replication forks. (PMID:21055983)
  • MMS22L and TONSL are required for the maintenance of genome stability. (PMID:21055984)
  • This study identifies MMS22L-NFKBIL2 as components of the replication stress control pathway. (PMID:21055985)
  • Results strongly suggest that the Mms22L-Nfkbil2 complex contributes to genome stability by regulating the chromatin state at stalled replication forks. (PMID:21113133)
  • Our data strongly suggest that targeting MMS22L as well as its interaction with NFKBIL2 could be a promising strategy for novel cancer treatments. (PMID:22895565)
  • new histones incorporated during DNA replication provide a signature of post-replicative chromatin, read by the human TONSL-MMS22L homologous recombination complex (PMID:27338793)
  • By specifically regulating RAD51 activity at uncoupled replication forks, MMS22L-TONSL stabilizes perturbed replication forks by promoting replication fork reversal and stimulating their homologous recombination-mediated restart in vivo. (PMID:27797818)
  • uncovered DNA-PKcs-dependent DNA damage-induced ASF1A phosphorylation, which enhances chromatin assembly, promoting MMS22L-TONSL recruitment and, hence, Rad51 loading. (PMID:29478807)
  • MMS22L-TONSL functions in sister chromatid cohesion in a pathway parallel to DSCC1-RFC. (PMID:36622344)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriomms22lENSDARG00000074691
mus_musculusMms22lENSMUSG00000045751
rattus_norvegicusMms22lENSRNOG00000006996
drosophila_melanogasterCG14803FBGN0023513

Protein

Protein identifiers

Protein MMS22-likeQ6ZRQ5 (reviewed: Q6ZRQ5)

Alternative names: Methyl methanesulfonate-sensitivity protein 22-like

All UniProt accessions (5): Q6ZRQ5, E2QRD4, H0Y8J1, H0YAJ2, H9KVD8

UniProt curated annotations — full annotation on UniProt →

Function. Component of the MMS22L-TONSL complex, a complex that promotes homologous recombination-mediated repair of double-strand breaks (DSBs) at stalled or collapsed replication forks. The MMS22L-TONSL complex is required to maintain genome integrity during DNA replication. It mediates the assembly of RAD51 filaments on single-stranded DNA (ssDNA): the MMS22L-TONSL complex is recruited to DSBs following histone replacement by histone chaperones and eviction of the replication protein A complex (RPA/RP-A) from DSBs. Following recruitment to DSBs, the TONSL-MMS22L complex promotes recruitment of RAD51 filaments and subsequent homologous recombination. Within the complex, MMS22L acts by binding ssDNA.

Subunit / interactions. Component of the MMS22L-TONSL complex, a complex at least composed of MMS22L and TONSL/NFKBIL2. Interacts with RAD51; interaction is direct.

Subcellular location. Nucleus. Chromosome.

Post-translational modifications. Degraded by the ubiquitin-proteasome system upon replication stress.

Similarity. Belongs to the MMS22 family. MMS22L subfamily.

RefSeq proteins (3): NP_001337528, NP_001337529, NP_940870 (=MANE)

Domains & families (InterPro)

IDNameType
IPR029424MMS22L_CDomain
IPR029425MMS22L_NDomain
IPR042320MMS22-likeFamily

Pfam: PF14910, PF14911

UniProt features (10 total): sequence variant 4, mutagenesis site 4, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZRQ5-F181.770.32

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Mutagenesis-validated functional residues (4):

PositionPhenotype
29–32does not affect interaction with rad51.
595–598does not affect interaction with rad51.
1034–1037abolished interaction with rad51.
1034abolished interaction with rad51.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 153 (showing top): GOBP_DNA_TEMPLATED_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY, GOCC_NUCLEAR_REPLICATION_FORK, GOBP_PROTEIN_LOCALIZATION_TO_CHROMATIN, GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME, GOBP_DNA_DAMAGE_RESPONSE, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, FISCHER_DREAM_TARGETS, GOBP_RECOMBINATIONAL_REPAIR, IK3_01, GOBP_DNA_REPLICATION, GOMF_SINGLE_STRANDED_DNA_BINDING, NUYTTEN_EZH2_TARGETS_DN, GOCC_MCM_COMPLEX, GAVIN_FOXP3_TARGETS_CLUSTER_P6, GOCC_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX

GO Biological Process (6): double-strand break repair via homologous recombination (GO:0000724), chromatin organization (GO:0006325), replication fork processing (GO:0031297), protein localization to chromatin (GO:0071168), DNA repair (GO:0006281), DNA damage response (GO:0006974)

GO Molecular Function (3): single-stranded DNA binding (GO:0003697), DNA binding (GO:0003677), protein binding (GO:0005515)

GO Cellular Component (9): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829), site of double-strand break (GO:0035861), nuclear replication fork (GO:0043596), site of DNA damage (GO:0090734), chromosome (GO:0005694), FACT complex (GO:0035101), MCM complex (GO:0042555)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
recombinational repair1
double-strand break repair1
cellular component organization1
DNA-templated DNA replication maintenance of fidelity1
protein localization to chromosome1
DNA metabolic process1
DNA damage response1
cellular response to stress1
DNA binding1
nucleic acid binding1
binding1
intracellular membrane-bounded organelle1
nuclear lumen1
cytoplasm1
site of DNA damage1
nuclear chromosome1
nucleus1
replication fork1
CMG complex1
chromosome1
intracellular membraneless organelle1
chromatin1
transcription elongation factor complex1
protein-containing complex1
MCM core complex1

Protein interactions and networks

STRING

1090 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MMS22LTONSLQ96HA7997
MMS22LESCO2Q56NI9658
MMS22LMCM5P33992623
MMS22LKLHL32Q96NJ5593
MMS22LSMARCAL1Q9NZC9548
MMS22LMCM3P25205523
MMS22LDDB1Q16531515
MMS22LSFT2D2O95562507
MMS22LRADXQ6NSI4495
MMS22LRAD51Q06609488
MMS22LASF1BQ9NVP2476
MMS22LMFAP3LO75121472
MMS22LGPR63Q9BZJ6462
MMS22LMCM6Q14566462
MMS22LZRANB3Q5FWF4455

IntAct

61 interactions, top by confidence:

ABTypeScore
MCM2MCM4psi-mi:“MI:0914”(association)0.830
H2AXPPM1Gpsi-mi:“MI:0914”(association)0.730
H2AC4PPM1Gpsi-mi:“MI:0914”(association)0.670
H2BC1PPM1Gpsi-mi:“MI:0914”(association)0.640
ASF1BHAT1psi-mi:“MI:0914”(association)0.640
NPY2RRTL8Cpsi-mi:“MI:0914”(association)0.530
NCR3LG1FAM171A2psi-mi:“MI:0914”(association)0.530
MACROH2A2PPM1Gpsi-mi:“MI:0914”(association)0.530
SSRP1PARP1psi-mi:“MI:0914”(association)0.530
H2BC26PPM1Gpsi-mi:“MI:0914”(association)0.530
H2AC18PPM1Gpsi-mi:“MI:0914”(association)0.530
ANKRD22ESYT2psi-mi:“MI:0914”(association)0.530
TONSLH2AC4psi-mi:“MI:0914”(association)0.530
TONSLMMS22Lpsi-mi:“MI:0915”(physical association)0.500
TONSLMMS22Lpsi-mi:“MI:0914”(association)0.500
RRP1BZNF785psi-mi:“MI:0914”(association)0.350
PACC1DEGS1psi-mi:“MI:0914”(association)0.350
PVRQSOX1psi-mi:“MI:0914”(association)0.350
OPRM1EXOC5psi-mi:“MI:0914”(association)0.350
H4C16psi-mi:“MI:0914”(association)0.350

BioGRID (123): MMS22L (Affinity Capture-MS), MMS22L (Synthetic Growth Defect), MMS22L (Co-purification), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS), MMS22L (Affinity Capture-MS)

ESM2 similar proteins: A0JM49, A2AKG8, B0V0U5, B1AUR6, C5J7W8, E1BGH8, E1C231, E1C2Z0, E7FGT5, E7FH61, E9Q3L2, F6S215, O08662, O60287, O94822, P42356, P57678, P78527, P97313, Q13315, Q13535, Q14146, Q1RLU1, Q2TAW0, Q3TQQ9, Q3URQ0, Q571H0, Q5RDK1, Q5VW36, Q5WNI9, Q5XI94, Q5ZM41, Q62388, Q6A009, Q6DFV1, Q6PQD5, Q6ZRQ5, Q7SY48, Q86XI2, Q8BKX6

Diamond homologs: B1AUR6, B3DIY3, E1BGH8, E1C2Z0, Q6ZRQ5

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 64 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
RNA Polymerase I Promoter Opening1043.9×8e-13
DNA methylation1042.5×9e-13
Packaging Of Telomere Ends841.8×8e-11
Defective pyroptosis1141.0×1e-13
SIRT1 negatively regulates rRNA expression1040.6×1e-12
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK31040.0×1e-12
Inhibition of DNA recombination at telomere1040.0×1e-12
ChAHP complex assembly939.5×1e-11

GO biological processes:

GO termPartnersFoldFDR
nucleosome assembly1433.9×1e-15
heterochromatin formation730.8×6e-07
DNA repair77.7×3e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

162 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance147
Likely benign13
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

5183 predictions. Top by Δscore:

VariantEffectΔscore
6:97146816:T:Cdonor_gain1.0000
6:97146840:T:Cdonor_gain1.0000
6:97150017:CTGC:Cacceptor_gain1.0000
6:97151868:C:CCacceptor_gain1.0000
6:97169387:T:Cdonor_gain1.0000
6:97173140:T:TAdonor_gain1.0000
6:97173219:CAGC:Cacceptor_gain1.0000
6:97173222:CCT:Cacceptor_loss1.0000
6:97173223:C:CCacceptor_gain1.0000
6:97173224:T:Aacceptor_loss1.0000
6:97178586:C:CCacceptor_gain1.0000
6:97179402:A:ACdonor_gain1.0000
6:97179403:C:CCdonor_gain1.0000
6:97179407:CCAA:Cdonor_gain1.0000
6:97179514:T:Cacceptor_gain1.0000
6:97179560:C:CCacceptor_gain1.0000
6:97186686:TACTC:Tacceptor_gain1.0000
6:97186688:CTC:Cacceptor_gain1.0000
6:97186689:TCCTA:Tacceptor_loss1.0000
6:97186691:C:CCacceptor_gain1.0000
6:97186692:T:Cacceptor_loss1.0000
6:97187395:C:CTacceptor_gain1.0000
6:97187396:A:Tacceptor_gain1.0000
6:97229400:TATT:Tacceptor_gain1.0000
6:97229402:TT:Tacceptor_gain1.0000
6:97229404:C:CCacceptor_gain1.0000
6:97231428:T:Adonor_gain1.0000
6:97246623:CATA:Cdonor_loss1.0000
6:97246624:ATAC:Adonor_loss1.0000
6:97246626:ACCTG:Adonor_loss1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000003949 (6:97226465 G>A), RS1000004668 (6:97195101 T>G), RS1000005920 (6:97192788 T>A,C,G), RS1000054910 (6:97148872 G>A,T), RS1000104896 (6:97276357 A>G), RS1000106732 (6:97148555 T>C), RS1000110006 (6:97190850 G>A), RS1000112245 (6:97283080 G>A,C), RS1000135885 (6:97177455 T>C), RS1000146516 (6:97198501 T>C,G), RS1000153795 (6:97228145 T>A,G), RS1000189001 (6:97270971 A>C,T), RS1000213893 (6:97168462 C>T), RS1000221591 (6:97186261 G>A), RS1000226137 (6:97226771 G>A,C,T)

Disease associations

OMIM: gene MIM:615614 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

35 associations (top):

StudyTraitp-value
GCST001834_1Oleic acid (18:1n-9) levels3.000000e-07
GCST002072_1Multiple sclerosis (OCB status)9.000000e-07
GCST002783_309Body mass index5.000000e-06
GCST002783_614Body mass index7.000000e-06
GCST003263_54Post bronchodilator FEV1 in COPD4.000000e-06
GCST003263_58Post bronchodilator FEV1 in COPD2.000000e-06
GCST003263_59Post bronchodilator FEV1 in COPD4.000000e-06
GCST003263_60Post bronchodilator FEV1 in COPD4.000000e-06
GCST003263_61Post bronchodilator FEV1 in COPD4.000000e-06
GCST003263_62Post bronchodilator FEV1 in COPD4.000000e-06
GCST003265_261Post bronchodilator FEV1/FVC ratio in COPD1.000000e-06
GCST003265_262Post bronchodilator FEV1/FVC ratio in COPD2.000000e-06
GCST003265_263Post bronchodilator FEV1/FVC ratio in COPD2.000000e-06
GCST003265_265Post bronchodilator FEV1/FVC ratio in COPD2.000000e-06
GCST003265_266Post bronchodilator FEV1/FVC ratio in COPD2.000000e-06
GCST003265_267Post bronchodilator FEV1/FVC ratio in COPD2.000000e-06
GCST003265_268Post bronchodilator FEV1/FVC ratio in COPD2.000000e-06
GCST003855_10Gut microbiota (bacterial taxa)2.000000e-08
GCST003855_11Gut microbiota (bacterial taxa)2.000000e-08
GCST003855_12Gut microbiota (bacterial taxa)2.000000e-08
GCST003855_13Gut microbiota (bacterial taxa)4.000000e-08
GCST003855_14Gut microbiota (bacterial taxa)4.000000e-08
GCST003992_39Photic sneeze reflex1.000000e-17
GCST004557_188Body mass index9.000000e-06
GCST004557_57Body mass index3.000000e-08
GCST004558_241Body mass index (joint analysis main effects and physical activity interaction)8.000000e-08
GCST004559_169Body mass index in physically active individuals2.000000e-07
GCST005830_56Hand grip strength1.000000e-08
GCST007326_77Number of sexual partners4.000000e-08
GCST007329_28Automobile speeding propensity3.000000e-08

EFO canonical traits (10, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0004314forced expiratory volume
EFO:0004713FEV/FVC ratio
EFO:0007874gut microbiome measurement
EFO:0007887autosomal dominant compelling helio-ophthalmic outburst syndrome
EFO:0008002physical activity measurement
EFO:0006941grip strength measurement
EFO:0008579risk-taking behaviour
EFO:0008328chronotype measurement
EFO:0009863anxiety measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases expression, increases expression, affects methylation4
bisphenol Adecreases expression2
Tobacco Smoke Pollutiondecreases expression2
Aflatoxin B1increases expression, increases methylation2
aristolochic acid Idecreases expression1
afuresertibdecreases expression1
triphenyl phosphateaffects expression1
propionaldehydedecreases expression1
2,2’-methylenebis(4-methyl-6-tert-butylphenol)affects expression, affects response to substance1
2-butenaldecreases expression1
beta-lapachoneincreases expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arsenitedecreases expression1
butyraldehydedecreases expression1
aflatoxin B2decreases methylation1
di-n-butylphosphoric acidaffects expression1
abrinedecreases expression1
(+)-JQ1 compounddecreases expression1
Dasatinibdecreases expression1
Sunitinibdecreases expression1
Calcitrioldecreases expression, affects cotreatment1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Melphalandecreases expression1
Testosteroneaffects cotreatment, decreases expression1
Tretinoindecreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideincreases expression1
Aflatoxin M1decreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.